BIRC3 up-regulates MAP3K7 levels to stimulate ERK1/2 phosphorylation, thereby driving epithelial-mesenchymal transition and the migratory and metastatic capacity of HCC in vitro and in vivo [28, 29]. Here, BIRC3 is linked to hepatocellular carcinoma.